Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
GC Medical Science corp.

Download Mobile App




Study of Biventricular Pacing in Heart Patients

By HospiMedica staff writers
Posted on 12 Sep 2000
Print article
A European multi-center trial has validated the therapeutic interest in biventricular pacing as resynchronization therapy in patients with severe heart failure and major intraventricular conduction delay, and shown that it has improved exercise tolerance, symptoms, and quality of life in patients in sinus rhythm treated with atrio-biventricular pacing. The trial, called the Multi-Site Stimulation in Cardiomyopathy (MUSTIC), was conducted under the auspices of the European Society of Cardiology.

The trial involved two patient groups. The first was composed of patients with congestive heart failure, chronic left ventricular systolic dysfunction, and signs of major ventricular asynchrony. Patients were implanted with a standard dual-chamber pacemaker, with an atrial port connected to the left ventricular lead and the ventricular port to the right ventricular lead. Patients were paced on or off in both ventricles but did not know whether they received biventricular pacing or not.

Biventricular pacing resulted in a slight but significant improvement in exercise tolerance, but the patients' quality of life, hospitalization rates, and mortality were not significantly different between the two pacing modes. Afterward, 87% of the patients said they preferred biventricular pacing. The results of this part of the trial were presented at the 22nd Congress of the European Society of Cardiology in Paris (France).

The second group of patients, who had normal sinus rhythm and no conventional indication for permanent cardiac pacing, were implanted with an atrio-biventricular pacemaker connected to three transvenous leads. The exercise tolerance in this group increased by 23% between the no-pacing and the pacing period. Hospitalization rates were found to be three times lower than in the no-pacing period. Afterward, 86% of the patients chose biventricular pacing as their preferred mode of therapy. The results of this part of the trial were reported earlier, at the 21st Scientific Sessions of the North American Society of Cardiac Pacing and Electrophysiology.
Gold Member
12-Channel ECG
CM1200B
Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
New
Vacuum-Assisted Breast Biopsy Device
Celero
New
Ultrasonic Cleaners
Large-Capacity Ultrasonic Cleaners

Print article

Channels

Surgical Techniques

view channel
Image: The stretchy hydrogel and a vial of liquid polymer (Photo courtesy of WPI)

New Class of Bioadhesives to Connect Human Tissues to Long-Term Medical Implants

Medical devices and human tissues differ significantly in their composition. While medical devices are primarily constructed from hard materials like metal and plastic, human tissue is soft and moist.... Read more

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.